Welcome : Guest

Arbutus Biopharma Corporation (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Arbutus Biopharma Corporation, which is principally a Therapeutic Solutions Company. Illustrated with 9 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-65512
Price: $450
Company Type: Public
Pages: 11
Date: November 2016
Market Data Tables: 9

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Arbutus Biopharma Corporation’s Revenues by Category (2015) in Percentage for Collaborations and Contracts Revenue (Department of Defense (DoD), Monsanto, and Dicerna) and Licensing Fees, Milestone and Royalty Payments (Monsanto Licensing Fees and Milestone Payments, Alnylam and Acuitas Licensing Fees and Milestone Payments, Dicerna Licensing Fee, and Spectrum Royalty Payments)......3
Table 2: Tekmira Pharmaceuticals Corporation’s Revenues by Category (2014) in Percentage for Collaborations and Contracts Revenue (Department of Defense (DoD), Monsanto, Bristol-Myers Squibb (BMS) and Dicerna) and Licensing Fees, Milestone and Royalty Payments (Monsanto Licensing Fees and Milestone Payments, Alnylam Milestone Payments, Dicerna Licensing Fee and Spectrum Royalty Payments)......4
Hepatitis B......5
Table 3: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......5
Table 4: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......6
Table 5: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......7
Hepatitis B Drugs......8
Table 6: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......8
Table 7: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......9
HBV/HCV Therapeutics......10
Table 8: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......10
Table 9: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......11